Background. We aimed to study respiratory syncytial virus (RSV) genotype distribution, clinical presentation, and disease severity in infants with bronchiolitis from RSV subtypes and new RSV genotypes.
The most common disease associated with respiratory syncytial virus (RSV) infection is bronchiolitis [1] . The known risk factors for severe bronchiolitis include very young age, premature birth, and underlying chronic diseases. Evidence from disease burden studies, however, suggested that most children hospitalized for bronchiolitis were previously healthy [2] . Despite intense investigation, no conclusive evidence has yet shown whether the severity of bronchiolitis and long-lasting sequelae are dependent on viral determinants (eg, viral load, RSV infecting genotype, and coinfection) [3, 4] .
RSV is an enveloped, negative-sense, single-stranded RNA virus, classified according to antigenic differences in virion structural proteins into 2 subtypes, A and B [5] . Both subtypes usually cocirculate during epidemic seasons, following an irregular, alternating prevalence pattern, subtype A having a cumulative higher prevalence than subtype B [6] . Although RSV-A is thought to have a more severe clinical course [7] [8] [9] [10] , several papers reported no significant differences in disease severity between the 2 subtypes [4, [11] [12] [13] [14] [15] [16] or found that RSV-B causes more severe disease than RSV-A [17] . This inconsistency could result from bias due to inclusion in these studies of infants with different respiratory diseases, differing in age, coming from different climates, or other confounding factors. Equally important, a different disease course may also reflect different RSV genotypes [10, 15, 16, 18, 19] . The RSV genome is more variable than previously thought [3, 16] . Novel genotypes with high genomic diversity may appear and, for many years, replace the dominant RSV genotypes. This occurred with the RSV-B genotype, first identified in 1999 in Buenos Aires (named BA), characterized by a 60-nucleotide (nt) duplication at the 3′ end of the G gene, which gradually replaced the older RSV-B genotypes [20] . More recently, an RSV-A genotype derived from NA1 acquired a 72-nt duplication in the G gene region corresponding to that in the BA genotype [21] . This novel genotype, named ON1, was first identified in Ontario [21] and rapidly spread worldwide [22] [23] [24] . Data comparing its clinical severity with that of other RSV genotypes are still limited and discordant [16, [24] [25] [26] [27] .
In this study we sought to understand whether RSV genotype and viral load influence the clinical presentation and disease severity in infants hospitalized for acute viral bronchiolitis. We also investigated whether infants with certain clinical and demographic characteristics might be more susceptible than others to infections with specific RSV subtypes and genotypes. To do so we assayed current RSV subtypes and specific genotypes in nasopharyngeal samples from a large cohort of infants hospitalized with clearly defined bronchiolitis over 12 epidemic seasons. To ensure that our findings specifically reflected RSV-related bronchiolitis we avoided enrolling infants with other RSV-related respiratory diseases and RSV coinfection with other respiratory viruses.
METHODS
Infants hospitalized for acute bronchiolitis in the Pediatric Emergency Department, Sapienza University of Rome, from 2005-2006 through 2016-2017 (September-May) were prospectively enrolled. Bronchiolitis was defined as the first episode of acute lower respiratory tract infection in infants less than 1 year old, characterized by the acute onset of cough, tachypnoea, retraction, and diffuse crackles (wheezing alone was insufficient for inclusion) [28] . Exclusion criteria were prematurity, recurrent wheezing, and underlying chronic diseases. Demographic and familial data were obtained from parents who gave written informed consent; clinical data were extracted from medical files. The study was approved by the Policlinico Umberto I institutional review board (Prot. 107/12).
On hospital admission, each infant was assigned a clinical severity score according to respiratory rate, arterial oxygen saturation, chest retractions, and ability to feed [28] .
Virus Detection
Within 24 hours after hospitalization, infants underwent nasopharyngeal washings; nucleic acid was extracted from a fresh aliquot, the remainder was stored at −80°C. A reverse transcriptase polymerase chain reaction (RT-PCR) was used to test for 14 respiratory viruses (RSV, influenza A/B, coronaviruses OC43, 229E, NL-63, HUK1, adenovirus, rhinovirus, parainfluenza 1-3, metapneumovirus, and bocavirus) as described [29] .
RSV Genotyping and RNA Quantification
From nasopharyngeal washings from infants with bronchiolitis positive for RSV alone, the second hypervariable half of the glycoprotein G gene was sequenced to assign the genotype [23] . Because about 20% of the archived RSV-positive nasopharyngeal washings from the first 4 epidemic seasons yielded no clear sequence data, they were designated as A or B by subtype-specific real-time PCR assay; these samples, that is 16 RSV-A and 1 RSV-B, were excluded from the genotype-specific analysis. Remaining sample material was assayed by quantitative real-time RT-PCR (qRT-PCR) as described elsewhere [30] . , and viral loads of the more recent RSV-positive cases (ON1 and BA) were measured during this study. Median viral load, expressed as the number of copies per mL of nasopharyngeal washing, were analyzed among groups or log 10 transformed.
Statistical Analysis
For categorical variables, either Pearson Χ 2 or Fisher exact test were used to test the statistical difference in proportion between 2 or 3 independent groups. For numerical variables, the 2-sample t test was used for comparing mean values and MannWhitney U for comparing the 2 groups when variables were nonnormally distributed. Two-way ANOVA was run to compare the mean values in 3 groups using NA1 as the reference group, and Kruskal-Wallis test for comparing nonnormally distributed data. Multinomial logistic regression was used to compare the 3 groups, NA1, ON1, and BA and calculate adjusted relative risk (aRR) as well as 95% confidence intervals (CI); an aRR with 95% CIs not including 1 was considered significant. In both models, to control for confounding variables (sex, age, season of birth, smoking, viral load expressed in log 10 ), we used a step-wise selection step and biologically plausible approaches. Spearman ρ coefficient was calculated to assess the correlation between the RSV load and patient age and weight, days of hospitalization, days of supplementary O 2 , and days in pediatric intensive care unit (PICU). A 2-way ANOVA was run to compare the mean log 10 viral load values and assess the association between log 10 loads and respiratory rate, oxygen saturation, supplementary O 2 therapy , radiographic consolidation and retraction levels (0-2), and PICU admission. P values less than 0.05 were considered to indicate statistical significance. Statistical data were analyzed using R Statistical Software [31] .
RESULTS

RSV Detection, Distribution, and Genotyping
A total of 998 infants with bronchiolitis were prospectively tested for respiratory viruses over 12 epidemic seasons RSV-A infected infants were significantly younger (P < .0001) had a lower body weight (P = .005) at admission (but not at birth), and were more frequently born in winter than in autumn, compared to infants infected with RSV-B (Table 1) . No differences were found in the patients' number of siblings or their attendance at school. RSV-A-infected infants had a slightly worse clinical presentation than RSV-B infants (P = .08), more frequent chest retractions (P = .020), and a significantly higher respiratory frequency (P = .003) but no differences between groups were found in oxygen saturation values, chest X-ray consolidations, or C-reactive protein levels.
The analysis comparing white blood cell counts between the 2 groups, showed higher eosinophil counts in the RSV-B than in the RSV-A subtype, both in the mean value/mm 3 (P = .039) and in the number of infants with values >400/mm 3 (P = .022, Table 1 ). Among known risk factors for asthma and atopy, RSV-B infants had a more frequent history of parental asthma than infants infected with RSV-A (P = .036); no differences between groups were found in breast feeding or in exposure to smoke.
Associations Between RSV Genotypes, Infant's Clinical and Demographic
Characteristics, and the Clinical Course of Bronchiolitis
A stratified analysis designed to differentiate clinical and demographic differences among the various RSV genotypes NA1, ON1, and BA indicated several differences in age and weight at hospital admission (but not in weight at birth). Both variables were lower in NA1 than in BA-infected infants, and slightly lower in the NA1 group than in the ON1 group, whereas no significant differences were found between weight at admission and the ON1 and BA genotypes ( Table 2) . No differences were found in the patients' number of siblings or their attendance at school.
The analysis of clinical data among the 3 genotypes identified further important differences: the presence of retractions and radiographic consolidations, respiratory rate, oxygen saturation, clinical severity score, and PICU admission rate were significantly worse in NA1 than in either ON1 or BA-infected infants ( Table 2 ). On the other hand, days of hospitalization, C-reactive protein values, the number of patients that were treated with supplementary O 2 therapy, and the days of O 2 therapy did not differ among genotypes. Length of hospitalization was not significantly different among RSV genotypes, probably because it was influenced by external factors not strictly related to illness severity (eg, socioeconomic status and nationality of the parents, delay of discharge on weekends and holidays, and hospital-acquired infections).
The analysis comparing differential white blood cell counts among the 3 patient groups, showed that the eosinophil count was higher in the BA than in the NA1 group, but not higher in the ON1 group. Concordant with this result, BA-infected infants were far more likely than those in the NA1 group, but no more likely than those in the ON1 group, to have parents with asthma ( Table 2 ). This analysis also found that both ON1-and BA-infected infants were more exposed than the NA1 group to passive smoking. Pearson Χ 2 test identified maternal smoking and maternal smoking during pregnancy as significantly more frequent in ON1-infected (P = .013) and BA-infected infants (P = .017).
The multinomial logistic regression analysis designed to investigate the potentially confounding influence of multiple factors (sex, age, season of birth, passive smoking, viral loads) on the clinical course of RSV infection overall confirmed the significant association of NA1 bronchiolitis infants with clinical variables, indicating a more severe clinical course of bronchiolitis. The aRR for having a higher respiratory rate, retractions and nasal flares, and radiographic consolidations was significantly higher in infants infected with NA1 than in those with RSV-BA. Oxygen saturation <90%, and days of oxygen therapy were not significantly different between NA1 and BA in the regression analysis. Similarly, NA1-infected infants had higher aRR for the same respiratory distress variables compared to infants infected with ON1. No differences were found in the aRR for presenting signs of respiratory distress between ON1 and RSV-BA infected infants, suggesting a similar clinical course. We found a lower aRR for presenting with fever at hospital admission in NA1 infants versus RSV-BA. The aRR for having parents with asthma was lower in infants infected with NA1 than infants infected with RSV-BA (Table 3 ).
Viral Load Analysis
The qRT-PCR assay used to determine RSV load (copy number of RSV-RNA/mL) in 286 infants (NA1, n = 103; ON1, n = 96; BA, n = 74), from whom enough residual sample was available for assay, showed that genotype-specific viral loads differed among groups. Infants infected with ON1 had significantly higher viral copies/mL than those infected with NA1 (MannWhitney: P < .0001) and those infected with BA (MannWhitney: P = .004). Expressing the viral load in log 10 copies/ mL yielded similar results (2-way ANOVA: P < .0001; Figure 2 ).
In the 3 RSV genotypes, viral load values were not correlated with respiratory rates, oxygen saturation in room air, radiographic consolidations, and retractions (Table 4) . Only in NA1-infected infants and not in ON1-or BA-infected infants (Table 4) , did viral load correlate moderately with age at hospital admission (Spearman ρ = 0.225; P = .023). Moreover, BA viral load correlated significantly with days of supplementary O 2 (Spearman ρ = 0.286; P = .036) and was significantly higher in patients with supplementary O 2 therapy (P = .023), with the worse severity score (P = .049) and with exposure to smoke (P = .042) (Table 4) . Thus, overall, viral load levels seemed to be relevant to RSV-BA pathogenesis, whereas in either RSV-A NA1 or ON1 these relationships were not found. 
DISCUSSION
One of the main findings highlighted when we assayed RSV subtypes and various RSV genotypes in infants hospitalized for acute viral bronchiolitis is that the severity of bronchiolitis depended on the specific infecting RSV genotype. RSV NA1-infected infants had more severe bronchiolitis than those infected with the new ON1 or BA genotypes. Despite intensive research, conclusive evidence is lacking on whether RSV subtypes A and B can cause a different presentation and clinical course in infants with bronchiolitis [4, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . Possible reasons for the inconsistency among studies include differences in study design, patient populations, specimen collection, and techniques used to detect RSV. Alternatively, these discrepancies may imply that the RSV genotypes differ in pathogenicity. In a previous study, Panayiotou et al [32] . reported that children aged <2 years infected with RSV ON1 experienced significantly milder acute respiratory infections than those infected with RSV NA1. Conversely, other studies reported a similar clinical course with the different genotypes [16, 25, 26, 28] or that genotype ON1 was associated with more severe respiratory distress in infants with pneumonia [27] . A distinctive point in this study is that our data were obtained in several epidemic seasons, in a homogenous group of infants with bronchiolitis, and excluding those with viral coinfections to ensure that our study yielded reliable findings. Even so, a single-center study may have limitations and a replication cohort may be needed to further test our hypothesis that RSV genotypes define disease presentation and severity. Nonetheless, further support came from the multinomial logistic regression analysis showing that infants infected with NA1 had higher aRR values for respiratory distress variables than those with RSV-BA and, similarly, NA1-infected infants had higher aRR values for respiratory distress variables than infants infected with ON1, regardless of age and other confounding factors such as sex, season of birth, passive smoking, and viral load.
Moreover, we compared RSV-ON1 loads with those of RSV-NA1 and BA genotypes and analyzed demographic and clinical data. Our results clearly showed that, despite its ability to replicate at high levels in infants, the clinical course of ON1 bronchiolitis was milder than that for the previously circulating RSV-A genotype, NA1. Importantly, viral load measurements have been conducted at different time points (see Methods) so that differential degradation of the RSV genome over time should not have affected the results. Others measured ON1 viral loads in nasopharyngeal swabs from infants with pneumonia in the Philippines [33] . Viral loads were higher in 17 NA1-infected than in 51 ON1-and 71 BA-infected children and correlated positively with younger age and clinical severity. The discrepancy with our study probably reflects the fact that others assessed viral loads for RSV genotypes only in children with pneumonia [33] . Because no published studies have yet compared patients' clinical severity between RSV-B genotypes with and without the insertion, we cannot conclude whether BA genotypes cause milder or more severe bronchiolitis than other RSV-B genotypes. .81 copies/mL; ON1, n = 96, mean log 10 6.92 copies/mL; BA n = 74, mean log 10 5.90 copies/mL. ANOVA: P < .0001. Another strong point in our study is that we compared infants' susceptibility to infection with a specific RSV genotype according to their clinical and demographic characteristics. In bronchiolitis cases, we found that infants infected with NA1 were younger than those infected with ON1 and BA. In earlier studies including ours [23, 25, 27] , ON1-infected children were younger than NA1, whereas other studies found no significant differences in patients' age [16, 26] . However, previous reports addressed only the first epidemic season in which ON1 circulated (2014) (2015) and examined all acute lower respiratory tract infections in children, mostly infants with pneumonia [16, 23, 26] .
In this study, another similarity we found in ON1-and BA-infected infants is that they were exposed more frequently than NA1-infected infants to passive smoking (familiar, maternal, and maternal during pregnancy). Previous reports have suggested a role for cigarette smoke exposure in bronchiolitis severity or in the risk for other acute lower respiratory tract infections, but others did not find this association [34] [35] [36] [37] . A possible explanation is that, from our results, there appears to be an interaction with the RSV genotype in the relationship between passive smoking and disease severity.
An original finding in our study is that infants hospitalized for bronchiolitis and infected with the RSV-B subtype had more risk factors for asthma and atopy (family history for asthma and blood eosinophilia) than infants infected with RSV-A. A more detailed analysis also showed similar genotype-related differences. Infants with the RSV-BA genotype, and to a lesser extent those with the ON1 genotype, had more risk factors for asthma and atopy than infants infected with genotype NA1. Further support came from the multinomial logistic regression analysis showing that the aRR for having a family member with asthma was strong with BA infection, and moderate with ON1, regardless of confounding factors such as age, family smoking, and viral load. These findings therefore imply that infants with risk factors for asthma are prone to hospitalization for bronchiolitis related to specific genotypes (ON1 and BA). Similarly, infants hospitalized for rhinovirus bronchiolitis typically are older, have high eosinophil counts, a less severe clinical course [28, 38] , and an increased risk of recurrent wheezing [38] and asthma [39] .
Severe RSV infection in early childhood might influence the type of T-helper (Th) cell response, thus predisposing infants to atopic asthma [40] . A question still to be answered is whether specific RSV genotype might be associated with different immune responses and thus alter the subsequent risk of asthma, due to viral factors determining a bias toward a Th2 response or to the infants' genetic background [2, 3, 38, 41] .
In conclusion, our study clearly indicates that the clinical course of bronchiolitis requiring hospitalization is related partly to the RSV subtype but more to the specific genotype. The less virulent RSV genotypes (ON1 and BA) preferentially cause bronchiolitis in infants with a possible genetic predisposition toward asthma and atopy. Accordingly, we conjecture that knowing the infecting RSV subtype and genotype could help predict and prevent the risk that otherwise healthy infants are hospitalized for bronchiolitis and experience a severe clinical course or respiratory sequelae.
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